Related Experiment Video
Updated: Jun 2, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries
Published on: November 28, 2025
[Hemostasis management based on ROTEM(®): contra]
1Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Germany. kehrel@uni-muenster.de
Point of care testing using rotational thromboelastometry (ROTEM) offers insights into perioperative hemostasis. However, relying solely on ROTEM for diagnostics is not recommended; it serves best as a supplementary tool for hemostasis specialists.
Area of Science:
- Anesthesiology and Critical Care Medicine
- Hematology
- Point-of-Care Diagnostics
Context:
- Perioperative hemostasis management is crucial for patient outcomes.
- Thromboelastometry, specifically ROTEM, is utilized in operating theaters for real-time hemostasis assessment.
- Therapeutic interventions are often guided by these diagnostic results.
Purpose:
- To critically evaluate the sole reliance on laboratory-based point-of-care diagnostic testing using ROTEM.
- To discuss the limitations and benefits of using ROTEM in perioperative hemostasis.
- To advocate for the appropriate integration of thromboelastometry within specialized hemostasis care.
Summary:
- This paper examines the use of rotational thromboelastometry (ROTEM) for point-of-care diagnostics during the perioperative phase.
- It argues against the exclusive use of laboratory-based ROTEM testing for clinical decision-making.
- Thromboelastometry is recommended as a supportive method, best utilized by or in close collaboration with hemostasis specialists.
Impact:
- Highlights the limitations of isolated diagnostic testing in complex hemostatic scenarios.
- Emphasizes the importance of expert interpretation in point-of-care hemostasis diagnostics.
- Promotes a collaborative approach between laboratory diagnostics and clinical hemostasis expertise for improved patient care.
More Related Videos
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management